Fecal pyruvate kinase: A potential new marker for intestinal inflammation in children with inflammatory bowel disease

Scandinavian Journal of Gastroenterology

Volumn 42, Issue 10, 2007, Pages 1147-1150

  Czub, Elzbieta ^a   Herzig, Karl Heinz ^b,i   Szaflarska Popławska, Anna ^c   Kiehne, Karlheinz ^d   Socha, Piotr ^e   Woś, Halina ^f   Kamińska, Barbara ^g   Błaszczyński, Michał ^h   Cichy, Wojciech ^h   Bała, Grazyna ^d   Brodzicki, Jacek ^g   Grzybowska Chlebowczyk, Urszula ^f   Walkowiak, Jarosław ^h  

^a Department of Infectious Diseases   (Poland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^f MEDICAL UNIVERSITY OF SILESIA   (Poland)

^g MEDICAL UNIVERSITY OF GDANSK   (Poland)

^h POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

ⁱ UNIVERSITY OF OULU   (Finland)

Author keywords

Crohn's disease; Fecal tests; Gastrointestinal inflammation; Pyruvate kinase; Ulcerative colitis

Indexed keywords

CALPROTECTIN; LACTOFERRIN; PYRUVATE KINASE;

ADOLESCENT; ADULT; ARTICLE; COMPARATIVE STUDY; CORRELATION ANALYSIS; CROHN DISEASE; ENTERITIS; FECES ANALYSIS; FEMALE; HUMAN; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; SCHOOL CHILD; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; CROHN DISEASE; FECES; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; PYRUVATE KINASE; REFERENCE VALUES;

EID: 35148855386     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520701320513     Document Type: Article

References (15)

1. Dubinsky MC, Ofman JJ, Urman M, Targan SR, Seidman EG. Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease. Am J Gastroenterol 2001;96:758-65.
2. Adeyem BO, Hodgson HJF. Faecal elastase reflects disease activity in active ulcerative colitis. Scand J Gastroenterol 1992;27:139-42.
3. Uchida K, Matsuse R, Tomita S, Sugi K, Saitoh O, Ohshiba S. Immunochemical detection of human lactoferrin in faeces as a new marker of inflammatory gastrointestinal disorders and colon cancer. Clin Biochem 1994;27:259-64.
4. Bunn SK, Bisset WM, Main MJC, Golden BE. Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2001;32:171-7.
5. Costa F, Mumolo MG, Bellini M, Romano MR, Ceccarelli P, Arpe P, et al. Role of faecal calprotectin as non-invasive marker of intestinal inflammation. Dig Liv Dis 2003;35: 642-7.
6. Kane SV, Sandborn WJ, Rufo PA, Zholudev A, Boone J, Lyerly D, et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol 2003;98:1309-14.
7. Walkowiak J, Banasiewicz T, Krokowicz P, Hansdorfer-Korzon R, Drews M, Herzig K-H. Fecal pyruvate kinase (M2-PK): A new predictor for inflammation and severity of pouchitis. Scand J Gastroenterol 2005;40:1493-4.
8. Kechemir D, Max-Audit I, Calvin-Preval MC, Rosa R. Purification of human leucocytes pyruvate kinase. J Chromatogr 1986;343:43.
9. McDowell G, Gupta S, Dellerba M, Coppinger T, Levy RD, Keevil BG. Plasma concentrations of tumour dimeric pyruvate kinase are increased in patients with chronic cardiac failure. Ann Clin Biochem 2004;41:491-3.
10. Oehler R, Weingartmann G, Manhart N, Salzer U, Meissner M, Schlegel W, et al. Polytrauma induces increased expression of pyruvate kinase in neutrophils. Blood 2000;95: 1086-92.
11. Hardt PD, Mazurek S, Toepler M, Schlierbach P, Bretzel RG, Eigenbrodt E, et al. Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer. Br J Cancer 2004;91:980-4.
12. Hyams JS, Ferry GD, Mandel FS, Gryboski JD, Kibort PM, Kirschner BS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991;12:439-47.
13. Mahadevan U, Loftus EV Jr, Tremaine WJ, Pemberton JH, Harmsen WS, Schleck CD, et al. Azathioprine or 6-mercaptopurine before colectomy for ulcerative colitis is not associated with increased postoperative complications. Inflamm Bowel Dis 2002;8:311-6.
14. Zhang B, Chen DD, Wang GB, Shen P. Tumor type M2 pyruvate kinase expression in gastric cancer, colorectal cancer and controls. World J Gastroenterol 2004;10: 1643-6.
15. Ventrucci M, Cipolla A, Racchini C, Casadei R, Simoni P, Gullo L. Tumor M2-pyruvate kinase, a new metabolic marker for pancreatic cancer. Dig Dis Sci 2004;49:1149-55.